Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-Label, Randomized Study of Single-Dose Subcutaneous Axatilimab Compared With Intravenous Axatilimab in Healthy Participants
Conditions
Interventions
Axatilimab
Locations
1
United States
Celerion, Inc
Tempe, Arizona, United States
Start Date
January 14, 2025
Primary Completion Date
June 6, 2025
Completion Date
June 10, 2025
Last Updated
June 25, 2025
NCT06342713
NCT07310901
NCT07401472
NCT07412353
NCT07280858
NCT07300189
Lead Sponsor
Incyte Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions